HIV prevention

“Trust us when we tell you what we need.”

A letter penned by Reps. Mondaire Jones and Ritchie Torres and signed by 56 others urges that a new injectable form of PrEP be as accessible as possible.

In England, 49% of new HIV cases were diagnosed in heterosexuals in 2020, while 45% were diagnosed in gay and bisexual men.

Apretude requires a shot every two months to effectively prevent the transmission of HIV.

Part of the money will go to funding access to PrEP.

Our community endured unspeakable trauma during the height of the HIV/AIDS epidemic. We learned from this fight. We want to help those in need.

Raymond Burke opposed condoms to save people from dying from HIV. Now he’s encouraging Italian Catholics to gather in churches despite the viral pandemic.

37 years after the city effectively forced bathhouses to close, a District supervisor may pave a way for them to reopen.

He would need to increase funding for PrEP, protect LGBTQ rights, and increase access to affordable health care.

The program makes sex education interactive and fun, which can save lives.

His case is the county’s second diagnosis.

Gay men with HIV are also 8 times more likely also to be diagnosed with syphilis, the CDC reports.

But they still won’t say why they wouldn’t provide a common medication before the public shamed them into protecting their employees.

He demanded answers from the notoriously conservative company. They gave him excuses instead.

The move took advocates by surprise, since it wasn’t expected until 2021. However, the announcement has led to confusion about how soon it might be available.

New calculations to better track HIV infections confirm that the U.S. is seeing a strong and steady decline.

A device to deliver a daily dose of an HIV prevention drug could be a huge leap forward in the fight against HIV/AIDS.

The hope is that this drug, injected once every 8 weeks, can safely protect men and transgender women from HIV infection

Our community has twice as many deaths from cigarettes than HIV every year. New advances can help us lower both rates by 95% or more.

Despite new treatment methods, Human Immunodeficiency Virus remains one of the most common and most dangerous STDs in the U.S.